This is a test
- 406 pages
- English
- PDF
- Available on iOS & Android
eBook - PDF
Age-Related Macular Degeneration, Third Edition
Book details
Table of contents
Citations
About This Book
The value of Age-Related Macular Degeneration has stood the test of time, but progress in both basic and clinical ophthalmology has been relentless, mandating the need for an updated book. This second edition focuses on the pathophysiology and the epidemiology of age-related macular degeneration (AMD), the clinical features and management of dry an
Frequently asked questions
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Both plans give you full access to the library and all of Perlegoâs features. The only differences are the price and subscription period: With the annual plan youâll save around 30% compared to 12 months on the monthly plan.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weâve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes, you can access Age-Related Macular Degeneration, Third Edition by Jennifer I. Lim in PDF and/or ePUB format, as well as other popular books in Medicina & Teoria, pratica e riferimenti medici. We have over one million books available in our catalogue for you to explore.
Information
Table of contents
- Front Cover
- Contents
- Contributors
- Foreword
- Preface
- 1. Histopathology of age-related macular degeneration
- 2. Immunology of age-related macular degeneration
- 3. Genetics of age-related macular degeneration
- 4. Choroidal neovascularization: VEGF pathways
- 5. Risk factors for age-related macular degeneration and choroidal neovascularization
- 6. Oxidative stress
- 7. Geographic atrophy
- 8. Non-neovascular age-related macular degeneration
- 9. Neovascular age-related macular degeneration
- 10. Polypoidal choroidal vasculopathy
- 11. Variants of neovascular age-related macular degeneration: Type 3 neovascularization (intraretinal neovascularization or retinal angiomatous proliferation)
- 12. Role of fluorescein angiography in the treatment of age-related macular degeneration
- 13. Use of indocyanine green angiography in the management of age-related macular degeneration
- 14. Role of optical coherence tomography in the evaluation of age-related macular degeneration
- 15. How to analyze OCT images for management of neovascular age-related macular degeneration
- 16. Fundus autofl uorescence imaging in age-related macular degeneration
- 17. Microperimetry and psychophysical testing to aid in the determination of progression of age-related macular degeneration
- 18. Laser photocoagulation for choroidal neovascularization
- 19. Anti-VEGF drugs and clinical trials
- 20. Non-VEGF related antiangiogenesis pathways for treatment of age-related macular degeneration
- 21. Radiation therapy for age-related macular degeneration
- 22. Combination therapy for age-related macular degeneration
- 23. Photodynamic therapy for neovascular age-related macular degeneration
- 24. Photocoagulation of AMD-associated CNV feeder vessels: An optimized approach
- 25. Macular translocation and other surgical treatments
- 26. Prophylactic treatment: The AREDS study results
- 27. Visual cycle modulation
- 28. Cellular transplantation for advanced age-related macular degeneration
- 29. Novel therapeutic interventions: Stem cells
- 30. Clinical considerations for visual rehabilitation
- 31. Visual prosthesis for age-related macular degeneration: A challenging and important application
- 32. Clinical research trials